Lehrstuhl für Genetik

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself (2021) Ferreira-Gomes M, Kruglov A, Durek P, Heinrich F, Tizian C, Heinz GA, Pascual-Reguant A, et al. Journal article Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study) (2021) Schifferli A, Ruefer A, Rovo A, Cantoni N, Holbro A, Favre G, Faeth H, et al. Conference contribution TUMOR-DERIVED GDF-15 PREVENTS THERAPY SUCCESS OF CHECKPOINT INHIBITORS BY BLOCKING T-LYMPHOCYTE RECRUITMENT (2021) Haake M, Schaefer T, Haack B, Vashist N, Genssler S, Harter P, Martens A, et al. Conference contribution There is strength in numbers: Quantitation of Fc gamma receptors on murine tissue-resident macrophages (2021) Vorsatz C, Friedrich N, Nimmerjahn F, Biburger M Journal article IN VIVO STUDIES OF IMMUNOMODULATORY A-CTLA-4 ANTIBODY IN A HUMANIZED MOUSE MODEL (2021) Reitinger C, Nimmerjahn F Conference contribution Human CD22-transgenic, primary murine lymphoma challenges immunotherapies in organ-specific tumor microenvironments (2021) Gsottberger F, Brandl C, Wendland K, Petkovic S, Emmerich C, Erber R, Geppert CI, et al. Journal article Cloning of a passage-free SARS-CoV-2 genome and mutagenesis using red recombination (2021) Herrmann A, Jungnickl D, Cordsmeier A, Peter AS, Überla K, Enßer A Journal article Targeting B cells in the pre-phase of systemic autoimmunity globally interferes with autoimmune pathology (2021) Werner A, Schäfer S, Zaytseva O, Albert H, Lux A, Kristic J, Pezer M, et al. Journal article Pre-incubation of corneal donor tissue with sCD83 improves graft survival via the induction of alternatively activated macrophages and tolerogenic dendritic cells (2021) Peckert-Maier K, Schoenberg A, Wild A, Royzman D, Braun G, Stich L, Hadrian K, et al. Journal article A Phase II study to investigate the efficacy and safety of eltrombopag in combination with dexamethasone compared to dexamethasone as first-line treatment in adult patients with newly diagnosed primary ITP (XPAG-ITP) (2021) Binder M, Meyer O, Rummel M, Nimmerjahn F, Tesanovic T, Sauer T, Matzdorff A Conference contribution